RESIDEO TECHNOLOGIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RESIDEO TECHNOLOGIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,455	4,519	4,827	4,988	5,071	5,846	6,370	6,242	6,761	7,472
Cost of revenue	3,090	3,203	3,402	3,711	3,727	4,262	4,604	4,546	4,860	5,276
Gross profit	1,365	1,316	1,425	1,277	1,344	1,584	1,766	1,696	1,901	2,196
Research and development				87	74	86	111	109	111	167
Selling, general and administrative	870	871	932	932	889	909	974	960	1,138	1,266
Operating expenses						1,025	1,155	1,149	1,381	1,589
Operating income	530	445	493	258	311	559	611	547	520	607
Interest expense			20	69	63	48	54	65	81	135
Interest income		3	7	3
Other non-operating income	-185	-1	-4	-13	-147	-159	-139	9	-7	43
Pre-tax income	310	166	104	71	101	353	418	313	221	-457
Income tax	133	560	-301	35	64	111	135	103	105	70
Net income	177	-394	405	36	37	242	283	210	116	-527
EBITDA	594	512	559	338	397	647	705	645	664	802
EPS, basic	1.44	-3.22	3.31	0.29	0.30	1.68	1.94	1.43	0.62	-3.77
EPS, diluted	1.44	-3.22	3.30	0.29	0.29	1.63	1.90	1.42	0.61	-3.77
Shares, basic (weighted)	122	122	122	123	125	144	146	147	146	149
Shares, diluted (weighted)	122	122	123	123	126	148	149	148	149	149

Balance sheet

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	47	56	265	122	517	775	326	636	692	661
Receivables		779	821	817	863	876	1,002	973	1,023	1,073
Inventory		465	628	671	672	740	975	941	1,237	1,354
Other current assets		69	95	175	173	150	199	193	220	270
Total current assets		1,392	1,809	1,785	2,225	2,541	2,502	2,743	3,172	3,358
Property, plant and equipment	261	265	300	316	318	287	366	390	410	447
Lease right-of-use assets				137	133	141	191	192	248	327
Goodwill	2,594	2,648	2,634	2,642	2,691	2,661	2,724	2,705	3,072	3,100
Intangible assets		140	133	127	135	120	475	461	1,176	1,091
Other non-current assets		23	96	385	376	244	320	346	369	437
Total assets		4,473	4,972	5,128	5,610	5,853	6,387	6,645	8,199	8,433
Accounts payable		678	964	920	936	883	894	905	1,073	1,131
Accrued liabilities		409	503	552	595	601	640	620	717	624
Deferred revenue						94	98	4	29
Short-term debt			22	22	7	10	12	12	6	18
Total current liabilities		1,147	1,489	1,494	1,538	1,494	1,546	1,525	1,790	1,755
Long-term debt			1,179	1,158	1,155	1,220	1,404	1,396	1,983	3,167
Lease liabilities				111	107	120	166	166	212	289
Other non-current liabilities		346	142	280	334	302	328	366	534	594
Total liabilities		1,870	3,439	3,526	3,617	3,601	3,858	3,896	4,890	5,516
Total debt			1,201	1,180	1,162	1,243	1,431	1,419	2,015	3,231
Paid-in capital			1,720	1,761	2,070	2,121	2,176	2,226	2,315	2,391
Retained earnings			2	38	75	317	600	810	907	345
Treasury stock				-3	-6	-21	-35	-93	-111	-144
Other comprehensive income		-100	-189	-194	-146	-165	-212	-194	-284	-157
Shareholders' equity	2,874	2,603	1,533	1,602	1,993	2,252	2,529	2,749	3,309	2,917
Total equity	2,874	2,603	1,533	1,602	1,993	2,252	2,529	2,749	3,309	2,917
Total liabilities and equity		4,473	4,972	5,128	5,610	5,853	6,387	6,645	8,199	8,433
Shares outstanding		123	122	123	143	145	146	145	147	150

Cash flow statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	177	-394	405	36	37	242	283	210	116	-527
Depreciation and amortization	64	67	66	80	86	88	94	98	144	195
Stock-based compensation	13	16	20	25	29	39	50	44	59	57
Deferred income tax	-4	297	-323	-25	22	6	-3	-28	-31	8
Change in receivables	-106	-31	-62	7	-27	-30	-72	19	-18	-29
Change in inventory	-49	-17	-172	-44	19	-73	-122	32	-71	-92
Change in payables	61	11	231	-38	-1	-42	-43	18	127	30
Cash from operations	151	37	462	23	244	315	152	440	444	-1,137
Capital expenditures	-60	-49	-64		-70	-63	-85	-105	-80	-116
Acquisitions	-120			-17	-35	-11	-665	-16	-1,337	0
Cash from investing	-191	-51	-74	-112	-103	-65	-764	-44	-1,409	-39
Debt issued			1,225		0	1,250	200	0	1,176	1,198
Debt repaid				-22	-22	-1,188	-12	-12	-605	-9
Stock issued						9		0	0	7
Share buybacks						0	0	-41	-1	0
Cash from financing	4	21	-167	-53	253	20	170	-64	1,031	1,128
Net change in cash	-35	9	209	-143	395	262	-450	308	56	-31
Free cash flow	91	-12	398		174	252	67	335	364	-1,253
Interest paid				72	57	39	54	80
Income taxes paid	136	261	28	86	32	107	159	123	162	93

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $18.27 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	29.6%	Gross profit / revenue.
Operating margin	6.9%	Operating income / revenue.
EBITDA margin	9.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	6.4%	Pre-tax income / revenue.
Net margin	5.6%	Net income / revenue.
FCF margin	-18.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-16.6%	Cash from operations / revenue.
Effective tax rate	12.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.9%	Net income / average total assets.
Return on invested capital (ROIC)	7.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.4%	Research and development expense / revenue.
SG&A / revenue	17.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	10.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	15.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	16.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-0.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	14.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	20.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	4.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	15.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-554.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-718.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-356.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-444.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-11.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	9.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.22x	Current assets / current liabilities.
Quick ratio	1.02x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.32x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.20x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	41.2%	Total debt / total assets.
Liabilities / assets	65.8%	Total liabilities / total assets.
Net debt	$3.07B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.23x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.94x	Operating income / interest expense.
Working capital	$2.10B	Current assets - current liabilities.
Goodwill and intangibles / assets	47.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.13B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.87x	Revenue / average total assets.
Fixed asset turnover	17.2x	Revenue / average property, plant and equipment.
Inventory turnover	3.87x	Cost of revenue / average inventory.
Days inventory	94 days	365 x average inventory / cost of revenue.
Receivables turnover	6.30x	Revenue / average receivables.
Days sales outstanding	58 days	365 x average receivables / revenue.
Days payables	76 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	77 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-327.6%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.77	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$49.69	Revenue / diluted weighted shares.
FCF per share	-$9.08	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$8.24	Cash from operations / diluted weighted shares.
Book value per share	$19.78	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$7.44	Tangible book value / shares outstanding.
Cash per share	$3.61	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.77B	Share price x shares outstanding.
Enterprise value	$5.85B	Market cap + total debt - cash - short-term investments.
P/E	6.50x	Market cap / net income. Only when net income is positive.
P/S	0.36x	Market cap / revenue.
P/B	0.92x	Market cap / shareholders' equity. Only when equity is positive.
EV/Sales	0.76x	Enterprise value / revenue.
EV/EBIT	11.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.04x	Enterprise value / EBITDA, when both are positive.
FCF yield	-50.4%	Free cash flow / market cap.
Earnings yield	15.4%	Net income / market cap (the inverse of P/E).

What was RESIDEO TECHNOLOGIES, INC.'s revenue in fiscal 2025?

RESIDEO TECHNOLOGIES, INC. reported revenue of $7.47B for fiscal 2025, 10.5% higher than the year before.

Was RESIDEO TECHNOLOGIES, INC. profitable in fiscal 2025?

No. It reported a net loss of $527.0M.

How much free cash flow did RESIDEO TECHNOLOGIES, INC. generate in fiscal 2025?

Cash from operations of $1.14B minus capital expenditures of $116.0M left free cash flow of -$1.25B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RESIDEO TECHNOLOGIES, INC.